Theramex news

This website is intended for an international audience. To view your own country’s website if available, please select your country from the list provided.

View your own country’s website

Australia
België
Belgique
Brazil
Deutsch
España
France
Italia
Netherlands
Polski
Portugal
UK

21 October 2025

Building Stronger Futures: Supporting Women’s Health on World Osteoporosis Day

20 December 2024

Theramex Announces European Commission Approval for Yselty®▼ (linzagolix) for Symptomatic Treatment of Endometriosis in Women with a History of Previous Medical or Surgical Treatment for their Endometriosis

13 September 2024

A dedicated women's health company

Understanding contraceptive options to meet your needs

Supporting you through the menopause

Helping you thrive through osteoporosis

Helping you through the challenges of fertility

Our diverse portfolio helps us deliver on our commitment to Women's Health

Get in touch

Careers

Theramex news

Building Stronger Futures: Supporting Women’s Health on World Osteoporosis Day

Theramex Announces European Commission Approval for Yselty®▼ (linzagolix) for Symptomatic Treatment of Endometriosis in Women with a History of Previous Medical or Surgical Treatment for their Endometriosis

Theramex announces the first sale of Yselty®▼ (linzagolix) in Germany

Read more about Theramex

Theramex news

Building Stronger Futures: Supporting Women’s Health on World Osteoporosis Day

Theramex Announces European Commission Approval for Yselty®▼ (linzagolix) for Symptomatic Treatment of Endometriosis in Women with a History of Previous Medical or Surgical Treatment for their Endometriosis

Theramex announces the first sale of Yselty®▼ (linzagolix) in Germany

Read more about Theramex

You're about to leave our website